Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis

Published:2007 Issue:2 Volume:502 Page:236-260
ISSN:0021-9967
Container-title:The Journal of Comparative Neurology
language:en
Short-container-title:J. Comp. Neurol.

Author:

Brown David A.,Sawchenko Paul E.

Publisher

Wiley

Subject

General Neuroscience

Reference66 articles.

1. Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis

2. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice

3. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.

4. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

5. Antibodies to CD44 and integrin 4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired olfactory performance and anxiety-like behavior in a rat model of multiple sclerosis are associated with enhanced adenosine signaling in the olfactory bulb via A1R, A2BR, and A3R;Frontiers in Cellular Neuroscience;2024-07-30

2. Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology;Cell;2024-04

3. Characterization of cortico-meningeal translocator protein expression in multiple sclerosis;Brain;2024-01-30

4. Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases;Cellular and Molecular Life Sciences;2024-01-12

5. hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS);Nature Communications;2024-01-08